E Autret-Leca, S Bauer, C Alberti, A-P Jonville-Béra, Y Aujard, L Bensouda-Grimaldi, O Baud
BACKGROUND AND AIM: In 1999, 80% of French neonatal centers used corticosteroids, mainly betamethasone (BMT), to prevent or treat bronchopulmonary dysplasia (BPD) [Lee SK, McMillan DD, Ohlson A, et al. Variations in practice and outcomes in the canadian NICU Network 1996-1997. Pediatrics 2000;106:1070-9]. As many data suggested a low risk-benefit ratio, an updated assessment of this use was necessary [Desnoulez L, Empana J, Anceschi M, et al. Prise en charge de l'immaturité pulmonaire en néonatologie : enquête sur les pratiques européennes...
July 2009: Archives de Pédiatrie: Organe Officiel de la Sociéte Française de Pédiatrie